Francisco JBaraonaMDFCCP

Clinical Trials

• Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients Start of enrollment: 2007 Oct 01

  Unknown status

  Phase 2

• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma Start of enrollment: 2004 Jul 01

  Completed

  Phase 2

• Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies Start of enrollment: 2017 Dec 21

  Terminated

  Phase 1, Phase 2

• Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas Start of enrollment: 2011 Nov 01

  Completed

  Phase 1

• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer Start of enrollment: 2001 Nov 01

  Completed

  Phase 2

• A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology. Start of enrollment: 2011 Apr 14

  Completed

  Phase 1

• Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases Start of enrollment: 2017 Nov 22

  Recruiting

  Phase 1

• Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058) Start of enrollment: 2007 Mar 01

  Completed

  Phase 1

• Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2006 May 01

  Terminated

  Phase 2

• Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery Start of enrollment: 2017 Dec 20

  Completed

  Phase 2

• Join now to see all